BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15534701)

  • 1. Combined use of physicochemical data and small-molecule crystallographic contact propensities to predict interactions in protein binding sites.
    Nissink JW; Taylor R
    Org Biomol Chem; 2004 Nov; 2(22):3238-49. PubMed ID: 15534701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SuperStar: comparison of CSD and PDB-based interaction fields as a basis for the prediction of protein-ligand interactions.
    Boer DR; Kroon J; Cole JC; Smith B; Verdonk ML
    J Mol Biol; 2001 Sep; 312(1):275-87. PubMed ID: 11545602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain-based small molecule binding site annotation.
    Snyder KA; Feldman HJ; Dumontier M; Salama JJ; Hogue CW
    BMC Bioinformatics; 2006 Mar; 7():152. PubMed ID: 16545112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SuperStar: improved knowledge-based interaction fields for protein binding sites.
    Verdonk ML; Cole JC; Watson P; Gillet V; Willett P
    J Mol Biol; 2001 Mar; 307(3):841-59. PubMed ID: 11273705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DrugScore(CSD)-knowledge-based scoring function derived from small molecule crystal data with superior recognition rate of near-native ligand poses and better affinity prediction.
    Velec HF; Gohlke H; Klebe G
    J Med Chem; 2005 Oct; 48(20):6296-303. PubMed ID: 16190756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FlexX-Scan: fast, structure-based virtual screening.
    Schellhammer I; Rarey M
    Proteins; 2004 Nov; 57(3):504-17. PubMed ID: 15382244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bridging Crystal Engineering and Drug Discovery by Utilizing Intermolecular Interactions and Molecular Shapes in Crystals.
    Spackman PR; Yu LJ; Morton CJ; Parker MW; Bond CS; Spackman MA; Jayatilaka D; Thomas SP
    Angew Chem Int Ed Engl; 2019 Nov; 58(47):16780-16784. PubMed ID: 31385643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SuperStar: a knowledge-based approach for identifying interaction sites in proteins.
    Verdonk ML; Cole JC; Taylor R
    J Mol Biol; 1999 Jun; 289(4):1093-108. PubMed ID: 10369784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of protein binding surfaces using surface triplet propensities.
    Mehio W; Kemp GJ; Taylor P; Walkinshaw MD
    Bioinformatics; 2010 Oct; 26(20):2549-55. PubMed ID: 20819959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule annotation for the Protein Data Bank.
    Sen S; Young J; Berrisford JM; Chen M; Conroy MJ; Dutta S; Di Costanzo L; Gao G; Ghosh S; Hudson BP; Igarashi R; Kengaku Y; Liang Y; Peisach E; Persikova I; Mukhopadhyay A; Narayanan BC; Sahni G; Sato J; Sekharan M; Shao C; Tan L; Zhuravleva MA
    Database (Oxford); 2014; 2014():bau116. PubMed ID: 25425036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDB-Ligand: a ligand database based on PDB for the automated and customized classification of ligand-binding structures.
    Shin JM; Cho DH
    Nucleic Acids Res; 2005 Jan; 33(Database issue):D238-41. PubMed ID: 15608186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DRoP: Automated detection of conserved solvent-binding sites on proteins.
    Kearney BM; Schwabe M; Marcus KC; Roberts DM; Dechene M; Swartz P; Mattos C
    Proteins; 2020 Jan; 88(1):152-165. PubMed ID: 31294888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. sc-PDB: an annotated database of druggable binding sites from the Protein Data Bank.
    Kellenberger E; Muller P; Schalon C; Bret G; Foata N; Rognan D
    J Chem Inf Model; 2006; 46(2):717-27. PubMed ID: 16563002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer simulation of protein-ligand interactions: challenges and applications.
    Hassan SA; Gracia L; Vasudevan G; Steinbach PJ
    Methods Mol Biol; 2005; 305():451-92. PubMed ID: 15940011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacology rescored: protein-ligand interaction profiles for remote binding site similarity assessment.
    Salentin S; Haupt VJ; Daminelli S; Schroeder M
    Prog Biophys Mol Biol; 2014; 116(2-3):174-86. PubMed ID: 24923864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of small-molecule structures to complement protein-ligand crystal structures in drug discovery.
    Groom CR; Cole JC
    Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):240-245. PubMed ID: 28291759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydration properties of ligands and drugs in protein binding sites: tightly-bound, bridging water molecules and their effects and consequences on molecular design strategies.
    García-Sosa AT
    J Chem Inf Model; 2013 Jun; 53(6):1388-405. PubMed ID: 23662606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-SITE: use of empirically derived atomic packing preferences to identify favourable interaction regions in the binding sites of proteins.
    Laskowski RA; Thornton JM; Humblet C; Singh J
    J Mol Biol; 1996 May; 259(1):175-201. PubMed ID: 8648645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-H...O, O-H...O, and C-H...O hydrogen bonds in protein-ligand complexes: strong and weak interactions in molecular recognition.
    Sarkhel S; Desiraju GR
    Proteins; 2004 Feb; 54(2):247-59. PubMed ID: 14696187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a genetic algorithm for flexible docking.
    Jones G; Willett P; Glen RC; Leach AR; Taylor R
    J Mol Biol; 1997 Apr; 267(3):727-48. PubMed ID: 9126849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.